Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6671270 | 0.85 | MAPT (0.54) | MAPTALDH1A1RECQLHSD17B10POLB | |
| SCHEMBL3662903 | 0.80 | ALDH1A1 (0.57) | MAPTALDH1A1RECQLHSD17B10POLB | |
| SCHEMBL1466162 | 0.80 | MEN1 (0.65) | MAPTALDH1A1RECQLHSD17B10POLB | |
| SCHEMBL6365853 | 0.79 | MAPT (0.51) | MAPTALDH1A1RECQLHSD17B10POLB | |
| Ammonia Solution, Strong SCHEMBL28461881 | 0.78 | MEN1 (0.63) | MAPTALDH1A1RECQLHSD17B10POLB | |
| SCHEMBL10511966 | 0.78 | MAPT (0.54) | MAPTALDH1A1RECQLHSD17B10POLB | |
| SCHEMBL10687645 | 0.76 | MAPT (0.49) | MAPTALDH1A1RECQLHSD17B10POLB | |
| SCHEMBL3859485 | 0.76 | ALDH1A1 (0.52) | MAPTALDH1A1RECQLHSD17B10POLB | |
| SCHEMBL3858400 | 0.75 | MEN1 (0.52) | MAPTALDH1A1RECQLHSD17B10POLB | |
| SCHEMBL12347503 | 0.75 | MEN1 (0.59) | MAPTALDH1A1RECQLHSD17B10POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1430019-B1 | SPHINGOLIPIDS | YISSUM RES DEV CO (IL) | 2009-12-30 | — | — | EP | disclosed |
| US-6756504-B2 | ENZYME INHIBITORS OF VARIOUS LIPID- RELATED ENZYMES, REDUCING LIPID ACCUMULATION, ANTICANCER AGENTS, ANTIMALARIA AGENTS, ANTIPROTOZOA AGENTS, ANTILIPOLYTIC AGENTS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2004-06-29 | — | — | US | disclosed |
| US-20030133904-A1 | Sphingolipids | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2003-07-17 | — | — | US | disclosed |
| US-5254333-A | Contains acidic dye, 2-benzyloxyethanol and a water-soluble nonionic polymer; imparts good feeling to hair; safe to hair and skin | KAO CORPORATION (JP) | 1993-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030133904-A1 | Sphingolipids | SMPD1, SMPD2, SGPL1 | MAPT 1868/4885ALDH1A1 817/4885RECQL 871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.